Latest Updates

Consolidated income from operations stood at ₹ 510.99 crore for the reported quarter

The medication is used to treat respiratory infections, skin infections, ear infections and sexually transmitted diseases

The estimated market size of Bivalirudin injection is US$ 101 million for the twelve months ending May 2018 according to IQVIA

The unit was inspected by EDQM during March 2018

Baddi facility gets US FDA nod for bulk drug 'Atorvastatin' and Masulkhana facility for 'Montelukast'

Wockhardt inaugurates a ‘state-of-the-art’ manufacturing facility for the production and packaging of sterile dry powder injection…

The product will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad

65 drugs inspector of FDCA participated in this knowledge sharing workshop

The event will focus on how the health of women will overall improve the health of the world

The international revenues are at INR 1,507 crore, around 72 per cent of sales